z-logo
open-access-imgOpen Access
Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
Author(s) -
Sherin Thalappil,
Maryam AlNesf
Publication year - 2022
Publication title -
qatar medical journal
Language(s) - English
Resource type - Journals
eISSN - 2227-0426
pISSN - 0253-8253
DOI - 10.5339/qmj.2022.fqac.4
Subject(s) - medicine , cox 2 inhibitor , pharmacology , dermatology , cyclooxygenase , biochemistry , chemistry , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom